Protective effect of Huashi Baidu formula against AKI and active ingredients that target SphK1 and PAI-1
Abstract Background Huashi Baidu Formula (HBF) is a clinical formula known for its efficacy against coronavirus disease 2019 (COVID-19).HBF may reduce the number of patients with abnormal serum creatinine while improving respiratory symptoms, suggesting that this formula may have potential for treating acute kidney injury (AKI).However, the protect